Shares of Esperion Theraptc (ESPR) are trading -7% lower at a price of $5.445 at the time of this writing.

Esperion Theraptc has been trading between a 52-week high of $15.09 and a 52-week low of $3.28. The stock has a market cap of $343 Million.

Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at Esperion is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.

UPDATE: Credit Suisse Downgrades Esperion Therapeutics to Underperform
Investing.com 08-03-22

Esperion Therapeutics (ESPR) Q2 2022 Earnings Call Transcript
The Motley Fool 08-02-22

Esperion Therapeutics PT Lowered to $13 at Cowen
Investing.com 08-02-22

Esperion Therapeutics Inc. (NASDAQ: ESPR): Stock Plunge On The Way?
Stocks Register 08-02-22

Esperion Therapeutics, Inc. 2022 Q2 - Results - Earnings Call Presentation (NASDAQ:ESPR)
Seeking Alpha 08-02-22